Effect of KRAS mutational status on disease behavior and treatment outcome in patients with metastatic colorectal cancer: intra-tumor heterogeneity and Mutational status

Faculty	Medicine	Year:	2019
Type of Publication:	ZU Hosted	Pages:
Authors:
Journal:	Journal of Gastrointestinal Oncology AME Publishing Company	Volume:

Keywords :	Effect , KRAS mutational status , disease behavior
Abstract:	-Nowadays, the outcomes of metastatic colorectal cancer (mCRC) have considerably improved. Genetic studies evaluating KRAS mutational status are important in the personalized therapy era to understand disease heterogeneity, disease behaviors, and treatment outcomes. -A major association between KRAS mutational status and both disease behavior and treatment outcomes was found in this study. Patients with KRAS mutation show advanced disease presentation, with lower PFS and overall survival.

Author Related Publications

Heba Fekry Abdel Majid Taha, "SPOP, ZEB-1 and E-cadherin expression in clear cell renal cell carcinoma (cc-RCC): Clinicopathological and prognostic significance", Elsevier,science direct, 2018 More
Amarallah Abdelmoneim Mohamed Sayed, "Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer", www.elsevier.com/locate/jnci, 2015 More
Shereen Mostafa Saleh Elshorbagy, "prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients – an immunohistochemical study", PMID: 35506035, 2022 More
Rasha Mohamed Mostafa Hagag, "Prognostic Value of Snail-1and Beta-Catenin Immunostaining in Astrocytoma.", International Journal of Advanced Research (2016), Volume 4, Issue 4, 1055-1066, 2016 More